Cite
HARVARD Citation
Berg, T. et al. (2019). Real‐world effectiveness and safety of glecaprevir/pibrentasvir for the treatment of chronic hepatitis C infection: data from the German Hepatitis C‐Registry. Alimentary pharmacology & therapeutics. 49 (8), pp. 1052-1059. [Online].